| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.35 | 4e-08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |